A detailed history of Huntington National Bank transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Huntington National Bank holds 239 shares of CDMO stock, worth $2,939. This represents 0.0% of its overall portfolio holdings.

Number of Shares
239
Previous 239 -0.0%
Holding current value
$2,939
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

BUY
$4.64 - $9.56 $1,108 - $2,284
239 New
239 $1,000
Q2 2023

Aug 11, 2023

BUY
$12.96 - $20.93 $738 - $1,193
57 Added 335.29%
74 $1,000
Q1 2023

May 10, 2023

BUY
$13.48 - $18.79 $229 - $319
17 New
17 $0
Q4 2019

Jan 17, 2020

SELL
$5.01 - $8.16 $3,582 - $5,834
-715 Closed
0 $0
Q1 2019

Apr 09, 2019

SELL
$3.56 - $4.82 $42 - $57
-12 Reduced 1.65%
715 $3,000
Q4 2018

Jan 28, 2019

BUY
$4.04 - $6.75 $2,937 - $4,907
727 New
727 $3,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $765M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.